Resistance-nodulation-division efflux pump acrAB is modulated by florfenicol and contributes to drug resistance in the fish pathogen Piscirickettsia salmonis.

Piscirickettsia salmonis is a fastidious intracellular pathogen responsible for high mortality rates in farmed salmonids, with serious economic consequences for the Chilean aquaculture industry. Oxytetracycline and florfenicol are the most frequently used antibiotics against P. salmonis, but routine use could contribute to drug resistance. This study identified differentiated florfenicol susceptibilities in two P. salmonis strains, LF-89 and AUSTRAL-005. The less susceptible isolate, AUSTRAL-005, also showed a high ethidium bromide efflux rate, indicating a higher activity of general efflux pump genes than LF-89. The P. salmonis genome presented resistance nodulation division (RND) family members, a family containing typical multidrug resistance-related efflux pumps in Gram-negative bacteria. Additionally, efflux pump acrAB genes were overexpressed in AUSTRAL-005 following exposure to the tolerated maximal concentration of florfenicol, in contrast to LF-89. These results indicate that tolerated maximum concentrations of florfenicol can modulate RND gene expression and increase efflux pump activity. We propose that the acrAB efflux pump is essential for P. salmonis survival at critical florfenicol concentrations and for the generation of antibiotic-resistant bacterial strains.

[1]  M. Mancilla,et al.  Comprehensive antibiotic susceptibility profiling of Chilean Piscirickettsia salmonis field isolates. , 2016, Journal of fish diseases.

[2]  A. Maass,et al.  Complete genome sequence of Piscirickettsia salmonis LF-89 (ATCC VR-1361) a major pathogen of farmed salmonid fish. , 2015, Journal of biotechnology.

[3]  Hiroshi Nikaido,et al.  The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria , 2015, Clinical Microbiology Reviews.

[4]  P. Manque,et al.  Draft Genome Sequence of Virulent Strain AUSTRAL-005 of Piscirickettsia salmonis, the Etiological Agent of Piscirickettsiosis , 2014, Genome Announcements.

[5]  J. Figueroa,et al.  Broth microdilution protocol for minimum inhibitory concentration (MIC) determinations of the intracellular salmonid pathogen Piscirickettsia salmonis to florfenicol and oxytetracycline. , 2014, Journal of fish diseases.

[6]  S. Marshall,et al.  Vaccination against Piscirickettsiosis , 2014 .

[7]  R. Enríquez,et al.  Piscirickettsiosis and Piscirickettsia salmonis in fish: a review. , 2014, Journal of fish diseases.

[8]  R. Edwards,et al.  Draft Genome Sequence of the Fish Pathogen Piscirickettsia salmonis , 2013, Genome Announcements.

[9]  J. Figueroa,et al.  Two novel blood-free solid media for the culture of the salmonid pathogen Piscirickettsia salmonis. , 2013, Journal of fish diseases.

[10]  F. Corona,et al.  The intrinsic resistome of bacterial pathogens , 2013, Front. Microbiol..

[11]  H. Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2009, Drugs.

[12]  J. Figueroa,et al.  Broth medium for the successful culture of the fish pathogen Piscirickettsia salmonis . , 2012, Diseases of aquatic organisms.

[13]  Hiroshi Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.

[14]  C. Briand,et al.  Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. , 2009, Journal of molecular biology.

[15]  Colin Hughes,et al.  The assembled structure of a complete tripartite bacterial multidrug efflux pump , 2009, Proceedings of the National Academy of Sciences.

[16]  D. Colquhoun,et al.  Real time PCR detection of Piscirickettsia salmonis from formalin-fixed paraffin-embedded tissues. , 2008, Journal of fish diseases.

[17]  L. Amaral,et al.  Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. , 2008, International journal of antimicrobial agents.

[18]  J. Molnár,et al.  An instrument-free method for the demonstration of efflux pump activity of bacteria. , 2006, In vivo.

[19]  K. Poole.  Efflux-mediated antimicrobial resistance. , 2005, The Journal of antimicrobial chemotherapy.

[20]  G. Kaatz.  Bacterial efflux pump inhibition. , 2005, Current opinion in investigational drugs.

[21]  J. Eswaran,et al.  Structure and function of TolC: the bacterial exit duct for proteins and drugs. , 2004, Annual review of biochemistry.

[22]  B. Porse,et al.  A conserved chloramphenicol binding site at the entrance to the ribosomal peptide exit tunnel. , 2003, Nucleic acids research.

[23]  H. Schweizer.  Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. , 2003, Genetics and molecular research : GMR.

[24]  Satoshi Murakami,et al.  Crystal structure of bacterial multidrug efflux transporter AcrB , 2002, Nature.

[25]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[26]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[27]  Kim Rutherford,et al.  Artemis: sequence visualization and annotation , 2000, Bioinform..

[28]  H. Nikaido,et al.  Cross-Linked Complex between Oligomeric Periplasmic Lipoprotein AcrA and the Inner-Membrane-Associated Multidrug Efflux Pump AcrB from Escherichia coli , 2000, Journal of bacteriology.

[29]  Colin Hughes,et al.  Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export , 2000, Nature.

[30]  S. Levy,et al.  Differential Expression of over 60 Chromosomal Genes in Escherichia coli by Constitutive Expression of MarA , 2000, Journal of bacteriology.

[31]  H. Nikaido.  Antibiotic resistance caused by gram-negative multidrug efflux pumps. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.